fda compounding semaglutide crackdown news today 2025 The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded (Wegovy) weight-loss pill from the Beyond the Headlines: FDA Warning

(Cited as one of the analyst sources for the 2026 or 2027 approval estimate referenced across the SERP.) Clinical Trials Arena

Its a much better deal than paying $1,000 per month or more out-of-pocket for name-brand prescriptions that are only sometimes covered by insurance, but, like most good things, those deals come with a pretty big asterisk

For instance, consuming well-rounded meals, discovering daily movement, and constructing a support network can assist individuals in maintaining weight loss for years, rather than months

Originally developed to treat type 2 diabetes, these drugs are now helping many people lose significant amounts of weight

Rybelsus: Rybelsus is approved to treat type 2 diabetes